Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 7124251, 9 pages
http://dx.doi.org/10.1155/2016/7124251
Research Article

Punicalagin Induces Serum Low-Density Lipoprotein Influx to Macrophages

1Department of Oxidative Stress and Human Diseases, MIGAL–Galilee Research Institute, 11016 Kiryat Shmona, Israel
2Tel-Hai College, 12208 Upper Galilee, Israel
3Faculty of Medicine in the Galilee, Bar-Ilan University, 1311502 Safed, Israel
4Eliachar Research Laboratory, Western Galilee Hospital, 22100 Nahariya, Israel

Received 24 January 2016; Revised 11 May 2016; Accepted 31 May 2016

Academic Editor: Gabriele Saretzki

Copyright © 2016 Dana Atrahimovich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Brown, P. T. Kovanen, and J. L. Goldstein, “Regulation of plasma cholesterol by lipoprotein receptors,” Science, vol. 212, no. 4495, pp. 628–635, 1981. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Kumar, S. J. Butcher, K. Öörni et al., “Three-dimensional cryoEM reconstruction of native LDL particles to 16å resolution at physiological body temperature,” PLoS ONE, vol. 6, no. 5, article e18841, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rosenblat and M. Aviram, “Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis,” Annals of Nutrition and Metabolism, vol. 58, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Aviram, L. Dornfeld, M. Kaplan et al., “Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans,” Drugs under Experimental and Clinical Research, vol. 28, no. 2-3, pp. 49–62, 2002. View at Google Scholar · View at Scopus
  5. M. Kaplan, T. Hayek, A. Raz et al., “Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis,” Journal of Nutrition, vol. 131, no. 8, pp. 2082–2089, 2001. View at Google Scholar · View at Scopus
  6. M. Rosenblat, N. Volkova, and M. Aviram, “Pomegranate phytosterol (β-sitosterol) and polyphenolic antioxidant (punicalagin) addition to statin, significantly protected against macrophage foam cells formation,” Atherosclerosis, vol. 226, no. 1, pp. 110–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Reiner, “Resistance and intolerance to statins,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 24, no. 10, pp. 1057–1066, 2014. View at Publisher · View at Google Scholar
  8. M. Aviram, L. Dornfeld, M. Rosenblat et al., “Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1062–1076, 2000. View at Google Scholar · View at Scopus
  9. N. P. Seeram, S. M. Henning, Y. Zhang, M. Suchard, Z. Li, and D. Heber, “Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours,” Journal of Nutrition, vol. 136, no. 10, pp. 2481–2485, 2006. View at Google Scholar · View at Scopus
  10. M. Medić-Šarić, V. Rastija, M. Bojić, and Ž. Maleš, “From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine,” Nutrition Journal, vol. 8, article 33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Fuhrman, S. Buch, J. Vaya et al., “Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” American Journal of Clinical Nutrition, vol. 66, no. 2, pp. 267–275, 1997. View at Google Scholar · View at Scopus
  12. D. Atrahimovich, J. Vaya, H. Tavori, and S. Khatib, “Glabridin protects paraoxonase 1 from linoleic acid hydroperoxide inhibition via specific interaction: a fluorescence-quenching study,” Journal of Agricultural and Food Chemistry, vol. 60, no. 14, pp. 3679–3685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Williams, J. P. E. Spencer, and C. Rice-Evans, “Flavonoids: antioxidants or signalling molecules?” Free Radical Biology and Medicine, vol. 36, no. 7, pp. 838–849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. P. Kulkarni, H. S. Mahal, S. Kapoor, and S. M. Aradhya, “In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin,” Journal of Agricultural and Food Chemistry, vol. 55, no. 4, pp. 1491–1500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Virgili and M. Marino, “Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity,” Free Radical Biology and Medicine, vol. 45, no. 9, pp. 1205–1216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D.-X. Hou and T. Kumamoto, “Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling,” Antioxidants and Redox Signaling, vol. 13, no. 5, pp. 691–719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Cuchel and D. J. Rader, “Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?” Circulation, vol. 113, no. 21, pp. 2548–2555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Aviram, “Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients,” Biochemical Medicine, vol. 30, no. 1, pp. 111–118, 1983. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Atrahimovich, J. Vaya, and S. Khatib, “The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study,” Bioorganic and Medicinal Chemistry, vol. 21, no. 11, pp. 3348–3355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Shpigelman, G. Israeli, and Y. D. Livney, “Thermally-induced protein-polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG,” Food Hydrocolloids, vol. 24, no. 8, pp. 735–743, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sun, H. Zhang, Y. Sun et al., “Study of interaction between protein and main active components in Citrus aurantium L. by optical spectroscopy,” Journal of Luminescence, vol. 130, no. 2, pp. 270–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Liang, H. A. Tajmir-Riahi, and M. Subirade, “Interaction of β-Lactoglobulin with resveratrol and its biological implications,” Biomacromolecules, vol. 9, no. 1, pp. 50–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Bass, J. W. Parce, and L. R. Dechatelet, “Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation,” Journal of Immunology, vol. 130, no. 4, pp. 1910–1917, 1983. View at Google Scholar · View at Scopus
  24. J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer, Berlin, Germany, 2006.
  25. C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez, “Polyphenols: food sources and bioavailability,” The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727–747, 2004. View at Google Scholar · View at Scopus
  26. M. R. Peluso, “Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver,” Experimental Biology and Medicine, vol. 231, no. 8, pp. 1287–1299, 2006. View at Google Scholar · View at Scopus
  27. E. Grotewold, The Science of Flavonoids, 2006.
  28. J. Xiao and G. Kai, “A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship,” Critical Reviews in Food Science and Nutrition, vol. 52, no. 1, pp. 85–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Bonneau, C. Vever-Bizet, P. Morlière, J.-C. Mazière, and D. Brault, “Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins,” Biophysical Journal, vol. 83, no. 6, pp. 3470–3481, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Flood, M. Gustafsson, R. E. Pitas, L. Arnaboldi, R. L. Walzem, and J. Borén, “Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 564–570, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. K. L. Ma, X. Z. Ruan, S. H. Powis, Y. Chen, J. F. Moorhead, and Z. Varghese, “Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice,” Hepatology, vol. 48, no. 3, pp. 770–781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Heber, “Pomegranate ellagitanins,” in Herbal Medicine: Biomolecular and Clinical Aspects, chapter 10, CRC Press, 2nd edition, 2011. View at Google Scholar